Tweaking Microtubules to Treat Scleroderma

by van Laar, Jacob M, Huizinga, Tom W. J
Published 2005

Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis

by Emery, Paul, Sebba, Anthony, Huizinga, Tom W J
Published 2013

Genetics of rheumatoid arthritis: what have we learned?

by Bax, Marieke, van Heemst, Jurgen, Huizinga, Tom W. J., Toes, Rene E. M.
Published 2011

Evaluation of the Disease Activity Score in Twenty‐Eight Joints–Based Flare Definitions in Rheumatoid Arthritis: Data From a Three‐Year Clinical Trial

by Dougados, Maxime, Huizinga, Tom W. J., Choy, Ernest H., Bingham, Clifton O., Aassi, Maher, Bernasconi, Corrado
Published 2015

Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply

by Markusse, Iris M., Lems, Willem F., Huizinga, Tom W.J., Allaart, Cornelia F.
Published 2015

Selective Involvement of the Amygdala in Systemic Lupus Erythematosus

by Emmer, Bart J, van der Grond, Jeroen, Steup-Beekman, Gerda M, Huizinga, Tom W. J, van Buchem, Mark A
Published 2006

Association between Several Clinical and Radiological Determinants with Long-Term Clinical Progression and Good Prognosis of Lower Limb Osteoarthritis

by Yusuf, Erlangga, Bijsterbosch, Jessica, Slagboom, P. Eline, Kroon, Herman M., Rosendaal, Frits R., Huizinga, Tom W. J., Kloppenburg, Margreet
Published 2011

An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression

by van der Helm-van Mil, Annette H. M., Knevel, Rachel, Cavet, Guy, Huizinga, Tom W. J., Haney, Douglas J.
Published 2013

The increased ability to present citrullinated peptides is not unique to HLA-SE molecules: arginine-to-citrulline conversion also enhances peptide affinity for HLA-DQ molecules

by Kampstra, Arieke S. B., van Heemst, Jurgen, Moustakas, Antonis K., Papadopoulos, George K., Huizinga, Tom W. J., Toes, René E. M.
Published 2016

When rheumatologists report that they agree with a guideline, does this mean that they practise the guideline in clinical practice? Results of the International Recommendation Impl...

by Gvozdenović, Emilia, Allaart, Cornelia F, van der Heijde, Désirée, Ferraccioli, Gianfranco, Smolen, Josef S, Huizinga, Tom W J, Landewé, Robert
Published 2016

Relationship of multi-biomarker disease activity score and other risk factors with radiographic progression in an observational study of patients with rheumatoid arthritis

by Li, Wanying, Sasso, Eric H., van der Helm-van Mil, Annette H. M., Huizinga, Tom W. J.
Published 2016

Fatigue in rheumatoid arthritis; a persistent problem: a large longitudinal study

by van Steenbergen, Hanna W, Tsonaka, Roula, Huizinga, Tom W J, Boonen, Annelies, van der Helm-van Mil, Annette H M
Published 2015

Body mass index and extent of MRI-detected inflammation: opposite effects in rheumatoid arthritis versus other arthritides and asymptomatic persons

by Mangnus, Lukas, Nieuwenhuis, Wouter P., van Steenbergen, Hanna W., Huizinga, Tom W. J., Reijnierse, Monique, van der Helm-van Mil, Annette H. M.
Published 2016

Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile

by van der Velden, Daniël, Lagraauw, H. Maxime, Wezel, Anouk, Launay, Pierre, Kuiper, Johan, Huizinga, Tom W. J., Toes, René E. M., Bot, Ilze, Stoop, Jeroen N.
Published 2016

Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis

by Fleischmann, Roy M, Huizinga, Tom W J, Kavanaugh, Arthur F, Wilkinson, Bethanie, Kwok, Kenneth, DeMasi, Ryan, van Vollenhoven, Ronald F
Published 2016

A prediction model for progressive disease in systemic sclerosis

by Meijs, Jessica, Schouffoer, Anne A, Ajmone Marsan, Nina, Stijnen, Theo, Putter, Hein, Ninaber, Maarten K, Huizinga, Tom W J, de Vries-Bouwstra, Jeska K
Published 2015

Retraction Note: Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium

by Suurmond, Jolien, Dorjée, Annemarie L., Boon, Mariëtte R., Knol, Edward F., Huizinga, Tom W. J., Toes, René E. M., Schuerwegh, Annemie J. M.
Published 2015

Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the r...

by Huizinga, Tom W J, Fleischmann, Roy M, Jasson, Martine, Radin, Allen R, van Adelsberg, Janet, Fiore, Stefano, Huang, Xiaohong, Yancopoulos, George D, Stahl, Neil, Genovese, Mark C
Published 2014

Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a...

by Emery, Paul, Burmester, Gerd R, Bykerk, Vivian P, Combe, Bernard G, Furst, Daniel E, Barré, Emilie, Karyekar, Chetan S, Wong, Dennis A, Huizinga, Tom W J
Published 2015

Antibodies Specific for Carbamylated Proteins Precede the Onset of Clinical Symptoms in Mice with Collagen Induced Arthritis

by Stoop, Jeroen N., Liu, Bi-Sheng, Shi, Jing, Jansen, Diahann T. S. L., Hegen, Martin, Huizinga, Tom W. J., Trouw, Leendert A., Toes, René E. M.
Published 2014